Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News IMV Inc IMVIQ

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.

Recent & Breaking News (GREY:IMVIQ)

IMV Announces CEO Transition

Business Wire August 4, 2021

IMV Inc. to Announce Second Quarter 2021 Results and Host a Conference Call and Webcast on August 11, 2021

Business Wire August 2, 2021

IMV to Participate in the BTIG Virtual Biotechnology Conference

Business Wire July 29, 2021

IMV Inc. Closes Previously Announced Public Offering

Business Wire July 20, 2021

IMV Inc. Announces Pricing of Public Offering

Business Wire July 15, 2021

IMV Inc. Files Preliminary Prospectus Supplement for Proposed Public Offering of Units

Business Wire July 14, 2021

IMV Announces Annual and Special Meeting of Shareholders Voting Results

Business Wire June 18, 2021

IMV Announces Appointment of Jeremy R. Graff, Ph.D. as Chief Scientific Officer And Addition of Clinical Advisor

Business Wire June 9, 2021

Independent Proxy Advisory Firms Recommend IMV Shareholders Vote for All Director Nominees at the Upcoming Annual General and Special Meeting

Business Wire June 8, 2021

IMV Inc. to Present at Two Upcoming Investor Conferences

Business Wire May 13, 2021

IMV Inc. Announces First Quarter 2021 Financial and Operational Results and Expansion of its Clinical Pipeline

Business Wire May 12, 2021

IMV Appoints Dr. Michael Kalos to Board of Directors

Business Wire May 11, 2021

IMV's Lead Immunotherapy to be Investigated in Breast Cancer

Business Wire May 10, 2021

IMV Inc. to Present at the Bloom Burton & Co. Healthcare Investor Virtual Conference

Business Wire April 13, 2021

IMV Announces Company-Sponsored Clinical Trial in Patients with r/rDLBCL in Collaboration with Merck Following Feedback from FDA

Business Wire April 7, 2021

IMV Appoints Kyle Kuvalanka to Board of Directors

Business Wire March 25, 2021

IMV Inc. Announces Fourth Quarter and Full Year 2020 Financial and Operational Results

Business Wire March 17, 2021

IMV to Announce Fourth Quarter and Fiscal 2020 Financial and Operational Results and Host Conference Call and Webcast on March 17, 2021

Business Wire March 8, 2021

IMV to Participate at the upcoming H.C. Wainwright Global Life Sciences Conference

Business Wire March 1, 2021

IMV to Participate in Two Upcoming Investor Events

Business Wire January 4, 2021